30
Participants
Start Date
January 18, 2022
Primary Completion Date
August 25, 2023
Study Completion Date
August 25, 2023
Placebo + Meal
Subjects will be directed to consume 1 placebo capsule containing maltodextrin, twice daily, for 21 days. Subjects will be directed to consume the capsules with their two largest meals, in between the third and second bites of food. During the MMTT, a placebo capsule will be consumed with a standardized test meal containing chicken, peas, potatoes, and butter.
BC-006 + Meal
Subjects will be directed to consume 1 capsule containing BC-006, twice daily, for 21 days. Subjects will be directed to consume the capsules with their two largest meals, in between the third and second bites of food. During the MMTT, a BC-006 capsule will be consumed with a standardized test meal containing chicken, peas, potatoes, and butter.
Freer Hall, Urbana
BIO-CAT, Inc.
INDUSTRY
University of Illinois at Urbana-Champaign
OTHER